Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Takeda (TOKYO:4502/NYSE:TAK) today announced that its Board of Directors decided on March 26, 2024 (CET) to propose candidates for Board of Directors at the 148th Ordinary General Meeting of Shareholders to be held on June 26, 2024.

Mr. Milano Furuta, currently president of the Japan Pharma Business Unit (JPBU), will succeed Mr. Constantine Saroukos as chief financial officer (CFO) effective April 1, 2024. Takeda will propose Mr. Furuta as a new candidate for board director at the Ordinary General Meeting of Shareholders. If approved by shareholders, Mr. Furuta will join the Board effective June 26, 2024.

Mr. Constantine Saroukos, who expressed his intention to retire as CFO, will leave the Board on June 26, 2024 upon the expiration of his term.

Candidates for Directors Who Are Not Audit and Supervisory Committee Members
Name	Category		Expected Role
Christophe Weber	Internal	Existing	Representative Director, President & Chief Executive Officer
Andrew Plump	Internal	Existing	Director, President, Research & Development
Milano Furuta	Internal	New	Director, Chief Financial Officer
Masami Iijima	External	Existing	External Director, Chair of the Board Meeting
Olivier Bohuon	External	Existing	External Director
Ian Clark	External	Existing	External Director
Steven Gillis	External	Existing	External Director
John Maraganore	External	Existing